Imuno
Leiden
About Imuno
Imuno develops a structure-based discovery engine to identify cancer-specific epitopes that can be exploited by novel therapeutic strategies. Its discovery engine identifies potential cross-reactive epitopes, providing a cohesive link with conventional in-vitro safety studies. It delivers missing information and better guidance to develop safe therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $338.6K
- Funding stage: Seed
- Last round: Seed (Nov 2021)
- Website: imunotx.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/imuno-22157 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.